|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.53 AUD | -1.84% |
|
+7.78% | -38.88% |
| 06:56am | Global drugmakers invest billions to boost US presence | RE |
| 06-12 | CSL partnership validates Clever Culture’s global growth strategy | FI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 36.8B | - | ||||
| 62.28B | |||||
| 60.59B | |||||
| 39.55B | |||||
| 29.53B | |||||
| 21.68B |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
